Jennifer A. Perry

The dTAG system for immediate and target-specific protein degradation

Behnam Nabet, Justin M. Roberts, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 1.2K citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Jennifer A. Perry, Adam Kieżun, Peter Tonzi et al. · Proceedings of the National Academy of Sciences · 2014 · 501 citations · Full text

Medicine, Cancer Biology, Oncology +17

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 468 citations · Full text

Medicine, Molecular Biology, Oncology +13

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia

Andrei V. Krivtsov, Kathryn Evans, Jayant Y. Gadrey et al. · Cancer Cell · 2019 · 449 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +14

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease

Carl R. Walkley, Rameez A. Qudsi, Vijay G. Sankaran et al. · Genes & Development · 2008 · 372 citations · Full text

Medicine, Genetics, Oncology +17